ResMed (RMD) Price/OCF Ratio: History & Chart

ResMed Inc.(RMD)

Medical - Instruments & Supplies · San Diego, CA

$229.28-1.59 (-0.69%)

Delayed quote: Sep 3, 2026, 2:50 PM EDT

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA

11,370 employees

www.resmed.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Michael J. Farrell

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
ResMed Inc. (RMD)	$33.26B	N/A	N/A	N/A	N/A
Biogen Inc. (BIIB)vs ›	$33.16B	11.50	11.06	14.34	15.45
Centene Corp. (CNC)vs ›	$33.48B	3.43	5.08	21.60	15.78
DexCom, Inc. (DXCM)vs ›	$33.80B	20.10	19.67	38.03	56.65
Zoetis Inc. (ZTS)vs ›	$32.06B	11.02	16.96	26.31	32.03
GE HealthCare Technologies Inc. (GEHC)vs ›	$31.52B	22.61	17.82	17.92	18.18
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$35.11B	58.26	113.61	1743.93	1743.93
Alcon Inc. (ALC)vs ›	$35.18B	15.51	17.12	22.34	24.97
Medline Inc. (MDLN)vs ›	$31.10B	15.69	19.92	19.92	19.92
Waters Corporation (WAT)vs ›	$30.83B	73.62	43.80	33.95	31.64

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

ResMed Inc. (RMD)

$33.26B

N/A

Biogen Inc. (BIIB)vs ›

$33.16B

11.50

11.06

14.34

15.45

Centene Corp. (CNC)vs ›

$33.48B

3.43

5.08

21.60

15.78

DexCom, Inc. (DXCM)vs ›

$33.80B

20.10

19.67

38.03

56.65

Zoetis Inc. (ZTS)vs ›

$32.06B

11.02

16.96

26.31

32.03

GE HealthCare Technologies Inc. (GEHC)vs ›

$31.52B

22.61

17.82

17.92

18.18

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$35.11B

58.26

113.61

1743.93

Alcon Inc. (ALC)vs ›

$35.18B

15.51

17.12

22.34

24.97

Medline Inc. (MDLN)vs ›

$31.10B

15.69

19.92

Waters Corporation (WAT)vs ›

$30.83B

73.62

43.80

33.95

31.64

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

RMD Price/OCF Ratio Metrics

RMD Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics